Lataa...
Cholinesterase inhibitors as Alzheimer's therapeutics
Alzheimer's disease (AD) is one of the most common forms of dementia. AD is a chronic syndrome of the central nervous system that causes a decline in cognitive function and language ability. Cholinergic deficiency is associated with AD, and various cholinesterase inhibitors have been developed...
Tallennettuna:
| Julkaisussa: | Mol Med Rep |
|---|---|
| Päätekijä: | |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
D.A. Spandidos
2019
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6625431/ https://ncbi.nlm.nih.gov/pubmed/31257471 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/mmr.2019.10374 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|